Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

54.35
Delayed Data
As of Nov 24
 0.00 / 0.00%
Today’s Change
53.63
Today|||52-Week Range
66.80
-7.68%
Year-to-Date
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Nov 24 / Zacks.com - Paid Partner Content
52-Week Company Lows
Nov 24 / GuruFocus News - Paid Partner Content
J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space
Nov 24 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: FDA Approves J&J, Glaxo HIV Drug, Roche Presents Data
Nov 24 / Zacks.com - Paid Partner Content
Cancer Space Update: 2 Drugs Receive Regulatory Nod in EU
Nov 24 / Zacks.com - Paid Partner Content
TESARO (TSRO) Ovarian Cancer Drug Zejula Gets Approval in EU
Nov 21 / Zacks.com - Paid Partner Content
Here's Why Merck Stock Is Down in 2017 Despite a Rising Industry
Nov 24 / Zacks.com - Paid Partner Content
Celldex (CLDX) Initiates Phase II Study on Cancer Candidate
Nov 20 / Zacks.com - Paid Partner Content
3 Companies Competing to Gain Lead in Ovarian Cancer Market
Nov 24 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: GE Cuts Dividend, Wal-Mart, Home Depot Beat
Nov 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close54.35
Today’s open54.50
Day’s range54.11 - 54.63
Volume4,341,296
Average volume (3 months)9,503,956
Market cap$148.3B
Dividend yield3.46%
Data as of 1:00pm ET, 11/24/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+4.31%
Earnings growth (next 5 years)+5.06%
Revenue growth (last year)+1.86%
P/E ratio52.3
Price/Sales4.15
Price/Book3.73

Competitors

 Today’s
change
Today’s
% change
NVSNovartis0.000.00%
PFEPfizer0.000.00%
SNYSanofi0.000.00%
ABBVAbbVie0.000.00%
Data as of 1:02pm ET, 11/24/2017

Financials

Next reporting dateFebruary 2, 2018
EPS forecast (this quarter)$0.94
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts